Literature DB >> 26994591

Bioengineered protein-based nanocage for drug delivery.

Eun Jung Lee1, Na Kyeong Lee2, In-San Kim3.   

Abstract

Nature, in its wonders, presents and assembles the most intricate and delicate protein structures and this remarkable phenomenon occurs in all kingdom and phyla of life. Of these proteins, cage-like multimeric proteins provide spatial control to biological processes and also compartmentalizes compounds that may be toxic or unstable and avoids their contact with the environment. Protein-based nanocages are of particular interest because of their potential applicability as drug delivery carriers and their perfect and complex symmetry and ideal physical properties, which have stimulated researchers to engineer, modify or mimic these qualities. This article reviews various existing types of protein-based nanocages that are used for therapeutic purposes, and outlines their drug-loading mechanisms and bioengineering strategies via genetic and chemical functionalization. Through a critical evaluation of recent advances in protein nanocage-based drug delivery in vitro and in vivo, an outlook for de novo and in silico nanocage design, and also protein-based nanocage preclinical and future clinical applications will be presented.
Copyright © 2016 Elsevier B.V. All rights reserved.

Keywords:  Bioengineering; Cancer therapy; Drug delivery; Functionalization; Protein-based nanocage

Mesh:

Substances:

Year:  2016        PMID: 26994591     DOI: 10.1016/j.addr.2016.03.002

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  35 in total

1.  Potato virus X, a filamentous plant viral nanoparticle for doxorubicin delivery in cancer therapy.

Authors:  Duc H T Le; Karin L Lee; Sourabh Shukla; Ulrich Commandeur; Nicole F Steinmetz
Journal:  Nanoscale       Date:  2017-02-09       Impact factor: 7.790

2.  High-throughput characterization of protein-protein interactions by reprogramming yeast mating.

Authors:  David Younger; Stephanie Berger; David Baker; Eric Klavins
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-31       Impact factor: 11.205

Review 3.  Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger.

Authors:  Mahdi Karimi; Parham Sahandi Zangabad; Fatemeh Mehdizadeh; Hedieh Malekzad; Alireza Ghasemi; Sajad Bahrami; Hossein Zare; Mohsen Moghoofei; Amin Hekmatmanesh; Michael R Hamblin
Journal:  Nanoscale       Date:  2017-01-26       Impact factor: 7.790

Review 4.  Intratumoral generation of 2-fluoroadenine to treat solid malignancies of the head and neck.

Authors:  Turang E Behbahani; Eben L Rosenthal; William B Parker; Eric J Sorscher
Journal:  Head Neck       Date:  2019-01-11       Impact factor: 3.147

Review 5.  Recent strategies towards the surface modification of liposomes: an innovative approach for different clinical applications.

Authors:  Amjad Ali Khan; Khaled S Allemailem; Saleh A Almatroodi; Ahmed Almatroudi; Arshad Husain Rahmani
Journal:  3 Biotech       Date:  2020-03-10       Impact factor: 2.406

Review 6.  Recent advances in porphyrin-based nanocomposites for effective targeted imaging and therapy.

Authors:  Navid Rabiee; Mohammad Tavakkoli Yaraki; Soha Mokhtari Garakani; Shima Mokhtari Garakani; Sepideh Ahmadi; Aseman Lajevardi; Mojtaba Bagherzadeh; Mohammad Rabiee; Lobat Tayebi; Mohammadreza Tahriri; Michael R Hamblin
Journal:  Biomaterials       Date:  2019-12-18       Impact factor: 12.479

Review 7.  Bacteriophage T4 nanoparticles for vaccine delivery against infectious diseases.

Authors:  Pan Tao; Jingen Zhu; Marthandan Mahalingam; Himanshu Batra; Venigalla B Rao
Journal:  Adv Drug Deliv Rev       Date:  2018-07-06       Impact factor: 15.470

Review 8.  The pharmacology of plant virus nanoparticles.

Authors:  Christian Isalomboto Nkanga; Nicole F Steinmetz
Journal:  Virology       Date:  2021-01-28       Impact factor: 3.616

9.  Nanocages displaying SIRP gamma clusters combined with prophagocytic stimulus of phagocytes potentiate anti-tumor immunity.

Authors:  Yoonjeong Choi; Gi-Hoon Nam; Gi Beom Kim; Seohyun Kim; Yoon Kyoung Kim; Seong A Kim; Ha-Jeong Kim; Eun Jung Lee; In-San Kim
Journal:  Cancer Gene Ther       Date:  2021-08-04       Impact factor: 5.987

10.  Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy.

Authors:  Xiaoyan Wang; Ming Wu; Xiaolong Zhang; Feida Li; Yongyi Zeng; Xinyi Lin; Xiaolong Liu; Jingfeng Liu
Journal:  J Nanobiotechnology       Date:  2021-07-08       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.